Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202841011 | Levothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1207768012 | Laevothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1208579015 | Levothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1475934015 | Laevothyroxine sodium+liothyronine sodium 100mcg/25mcg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1476895011 | Levothyroxine sodium+liothyronine sodium 100mcg/25mcg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3468066014 | Levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3468067017 | Product containing levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3486155019 | Product containing levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569423012 | Product containing only levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569424018 | Product containing only levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3680146018 | Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3680147010 | Levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3680148017 | Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 108316001000001118 | Levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each oral tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Is a | Liothyronine sodium preparation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has active ingredient | Liothyronine sodium | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has active ingredient | Liothyronine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Is a | Product containing levothyroxine sodium | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has active ingredient | Levothyroxine sodium | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Is a | Product containing levothyroxine sodium and liothyronine sodium | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Is a | Product containing liothyronine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Is a | Product containing levothyroxine sodium in oral dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has active ingredient | Liothyronine sodium | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has basis of strength substance | Liothyronine sodium | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 25 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has active ingredient | Levothyroxine sodium | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has basis of strength substance | Levothyroxine sodium | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has precise active ingredient | Liothyronine sodium | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has precise active ingredient | Levothyroxine sodium | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Is a | Product containing levothyroxine and liothyronine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Is a | Product containing only levothyroxine and liothyronine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has basis of strength substance | Levothyroxine sodium | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has precise active ingredient | Levothyroxine sodium | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has precise active ingredient | Liothyronine sodium | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet | Has basis of strength substance | Liothyronine sodium | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR